Gevertz JL[au] - Search Results

Year	Number of Results
2005	1
2006	1
2008	2
2011	1
2015	1
2016	4
2017	1
2018	1
2019	1
2020	1
2021	3
2022	2
2023	0

1

From Fitting the Average to Fitting the Individual: A Cautionary Tale for Mathematical Modelers.

Luo MC, Nikolopoulou E, Gevertz JL. Luo MC, et al. Among authors: gevertz jl. Front Oncol. 2022 Apr 28;12:793908. doi: 10.3389/fonc.2022.793908. eCollection 2022. Front Oncol. 2022. PMID: 35574407 Free PMC article.

2

Model-informed experimental design recommendations for distinguishing intrinsic and acquired targeted therapeutic resistance in head and neck cancer.

Cárdenas SD, Reznik CJ, Ranaweera R, Song F, Chung CH, Fertig EJ, Gevertz JL. Cárdenas SD, et al. Among authors: gevertz jl. NPJ Syst Biol Appl. 2022 Sep 8;8(1):32. doi: 10.1038/s41540-022-00244-7. NPJ Syst Biol Appl. 2022. PMID: 36075912 Free PMC article.

3

Correction to: Predicting the impact of placing an overdose prevention site in Philadelphia: a mathematical modeling approach.

Wares JR, Dong J, Gevertz JL, Radunskaya A, Viner K, Wiebe D, Solomon S. Wares JR, et al. Among authors: gevertz jl. Harm Reduct J. 2021 Dec 15;18(1):129. doi: 10.1186/s12954-021-00577-2. Harm Reduct J. 2021. PMID: 34911548 Free PMC article. No abstract available.

4

Predicting the impact of placing an overdose prevention site in Philadelphia: a mathematical modeling approach.

Wares JR, Dong J, Gevertz JL, Radunskaya A, Viner K, Wiebe D, Solomon S. Wares JR, et al. Among authors: gevertz jl. Harm Reduct J. 2021 Oct 30;18(1):110. doi: 10.1186/s12954-021-00559-4. Harm Reduct J. 2021. PMID: 34717657 Free PMC article.

5

Microenvironmental Niches and Sanctuaries: A Route to Acquired Resistance.

Pérez-Velázquez J, Gevertz JL, Karolak A, Rejniak KA. Pérez-Velázquez J, et al. Among authors: gevertz jl. Adv Exp Med Biol. 2016;936:149-164. doi: 10.1007/978-3-319-42023-3_8. Adv Exp Med Biol. 2016. PMID: 27739047 Free PMC article.

6

Microenvironment-Mediated Modeling of Tumor Response to Vascular-Targeting Drugs.

Gevertz JL. Gevertz JL. Adv Exp Med Biol. 2016;936:191-208. doi: 10.1007/978-3-319-42023-3_10. Adv Exp Med Biol. 2016. PMID: 27739049

7

Mathematical model of real-time PCR kinetics.

Gevertz JL, Dunn SM, Roth CM. Gevertz JL, et al. Biotechnol Bioeng. 2005 Nov 5;92(3):346-55. doi: 10.1002/bit.20617. Biotechnol Bioeng. 2005. PMID: 16170827

8

Mathematical Approach to Differentiate Spontaneous and Induced Evolution to Drug Resistance During Cancer Treatment.

Greene JM, Gevertz JL, Sontag ED. Greene JM, et al. Among authors: gevertz jl. JCO Clin Cancer Inform. 2019 Apr;3:1-20. doi: 10.1200/CCI.18.00087. JCO Clin Cancer Inform. 2019. PMID: 30969799 Free PMC article.

9

A novel COVID-19 epidemiological model with explicit susceptible and asymptomatic isolation compartments reveals unexpected consequences of timing social distancing.

Gevertz JL, Greene JM, Sanchez-Tapia CH, Sontag ED. Gevertz JL, et al. J Theor Biol. 2021 Feb 7;510:110539. doi: 10.1016/j.jtbi.2020.110539. Epub 2020 Nov 24. J Theor Biol. 2021. PMID: 33242489 Free PMC article.

10

Simulating tumor growth in confined heterogeneous environments.

Gevertz JL, Gillies GT, Torquato S. Gevertz JL, et al. Phys Biol. 2008 Sep 29;5(3):036010. doi: 10.1088/1478-3975/5/3/036010. Phys Biol. 2008. PMID: 18824788

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results